university website Publications by Year
  • Wealth
    • Erasmus Research Institute of Management (ERIM)
    • Erasmus School of Economics (ESE)
    • Rotterdam School of Management (RSM)
  • Health
    • Erasmus MC: University Medical Center Rotterdam
    • Erasmus School of Health Policy & Management (ESHPM)
  • Governance
    • Erasmus School of Law
    • Public Administration (FSS)
    • Netherlands Institute for Government (NIG)
    • Institute for Housing and Urban Development Studies (IHS)
  • Culture
    • Erasmus School of History, Culture and Communication (ESHCC)
    • Erasmus School of Social and Behavioural Sciences(ESSB)
    • Erasmus School of Philosophy (ESPhil)
    • International Institute of Social Studies (ISS)
  • Submissions
    • Submitting Publications
  • sign in
  • Department of Hematology /
  • Leukemia /
  • Article
  • Search

M. Cavo (Michele), L. Pantani, A. Pezzi (Angelo), M. Petrucci (Maria), F. Patriarca (Francesca), F. Di Raimondo (F.), G. Marzocchi, M. Galli, V. Montefusco (Vittorio), E. Zamagni (Elena), et al. B. Gamberi, P. Tacchetti (Paola), A. Brioli, A. Palumbo (Antonio) and P. Sonneveld (Pieter)

2015-12-01

Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma

Publication

Publication

Leukemia , Volume 29 - Issue 12 p. 2429- 2431

Additional Metadata
Persistent URL doi.org/10.1038/leu.2015.274, hdl.handle.net/1765/89063
Journal Leukemia
Rights no subscription
Organisation Department of Hematology
  • View at Publisher
  • View at Pubmed
  • View at Scopus


university website
  • About

    • Research Matters
    • Open Access
    • Privacy Statement
artudis website

Workflow

Workflow

Add Content


User Publication Person Organisation Collection
Close